Small-Cap Stocks Are Having a Moment. Check Out the 10 Biggest Winners.
The Russell 2000 has surged over the past five days as the so-called "Great Rotation" kicks off.
Pacific Biosciences of California Up Over 32%, on Pace for Largest Percent Increase Since November 2018 -- Data Talk
Pacific Biosciences of California, Inc. ( PACB ) is currently at $2.15, up $0.53 or 32.72% --Would be highest close since May 16, 2024, when it closed at $2.19 --On pace for largest percent increase
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of The Charles Schwab Corporation (NYSE:SCHW) fell sharply during Tuesday's session following second-quarter results.Charles Schwab said adjusted net income declined 2% Y/Y to $1.465 billion.
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 550 points on Tuesday.Shares of UnitedHealth Group Incorporated (NYSE:UNH) rose sharply during Tuesday's session following a
PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite index gaining around 100 points on Friday.Shares of The Bank of New York Mellon Corporation (NYSE:BK) rose during Friday's session following better-
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 100 points on Thursday.Shares of Methode Electronics, Inc. (NYSE:MEI) rose sharply during Thursday's session after the company
It's Down 28% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks
To the annoyance of some shareholders, Pacific Biosciences of California, Inc. (NASDAQ:PACB) shares are down a considerable 28% in the last month, which continues a horrid run for the company. For
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
Barclays Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2
Barclays analyst Luke Sergott maintains $Pacific Biosciences of California(PACB.US)$ with a hold rating, and maintains the target price at $2.According to TipRanks data, the analyst has a success rate
PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry
PacBio (PACB) and Form Bio, a provider of life sciences technology, said Thursday they are launching initiatives to advance and unify the adeno-associated viral, or AAV, gene therapy industry. Financi
Cathie Wood's Top and Bottom Performing ARKK Holdings of H1
Pacific Biosciences of California, Inc (PACB): A Good Buy According to Analysts?
Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices
Companies Form Expert Working Group to Introduce Essential Tools for AAV Development and Research ProfessionalsSAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computati
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.65, marking a -1.5% move from the previous day.
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders
Even though Pacific Biosciences of California, Inc. (NASDAQ:PACB) has fallen by 12% over the past week , insiders who sold US$3.1m worth of stock over the past year have had less luck. Insiders might
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease ResearchMENLO PARK, Calif., June 10, 2024 /PRNewswire/ -- PacBio
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB) in the last three months.The table below summarizes their rec
Express News | Jefferies Initiates Coverage On Pacific Biosciences With Buy Rating, Announces Price Target of $4
Express News | Pacific Biosciences of California Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $4